Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dyer

Showing results (591-600 of 610) with videos related to

Pageof 61
Sort By:
Plos One|September 15, 2009
A comprehensive microarray-based DNA methylation study of 367 hematological neoplasmsJose I Martin-Subero, Ole Ammerpohl, Marina Bibikova, et al.
Leukemia|November 4, 2014
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia riskG P Sava, H E Speedy, M C Di Bernardo, et al.
Blood|June 16, 2012
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemiaSusan L Slager, Christine F Skibola, Maria Chiara Di Bernardo, et al.
Oncotarget|May 8, 2018
S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growthPatrick Casara, James Davidson, Audrey Claperon, et al.
Nature Genetics|January 12, 2010
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia riskDalemari Crowther-Swanepoel, Peter Broderick, Maria Chiara Di Bernardo, et al.
Faraday Discussions|October 12, 2018
Structure searching methods: general discussionMatthew Addicoat, Claire S Adjiman, Mihails Arhangelskis, et al.
Current Research in Microbial Sciences|February 3, 2025
Comparative genomics of <i>Aspergillus nidulans</i> and section <i>Nidulantes</i>Sebastian Theobald, Tammi Vesth, Jane L Nybo, et al.
Blood Advances|June 23, 2022
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimenMeghan C Thompson, Rosemary A Harrup, Catherine C Coombs, et al.
Plos Genetics|April 12, 2008
Genomic islands in the pathogenic filamentous fungus Aspergillus fumigatusNatalie D Fedorova, Nora Khaldi, Vinita S Joardar, et al.
Nature Communications|June 15, 2016
Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamicsEloy F Robles, Maria Mena-Varas, Laura Barrio, et al.
Pageof 61

Showing results (591-600 of 610) with videos related to

Sort By:
Pageof 61
Plos One|September 15, 2009
A comprehensive microarray-based DNA methylation study of 367 hematological neoplasmsJose I Martin-Subero, Ole Ammerpohl, Marina Bibikova, et al.
Leukemia|November 4, 2014
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia riskG P Sava, H E Speedy, M C Di Bernardo, et al.
Blood|June 16, 2012
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemiaSusan L Slager, Christine F Skibola, Maria Chiara Di Bernardo, et al.
Oncotarget|May 8, 2018
S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growthPatrick Casara, James Davidson, Audrey Claperon, et al.
Nature Genetics|January 12, 2010
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia riskDalemari Crowther-Swanepoel, Peter Broderick, Maria Chiara Di Bernardo, et al.
Faraday Discussions|October 12, 2018
Structure searching methods: general discussionMatthew Addicoat, Claire S Adjiman, Mihails Arhangelskis, et al.
Current Research in Microbial Sciences|February 3, 2025
Comparative genomics of <i>Aspergillus nidulans</i> and section <i>Nidulantes</i>Sebastian Theobald, Tammi Vesth, Jane L Nybo, et al.
Blood Advances|June 23, 2022
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimenMeghan C Thompson, Rosemary A Harrup, Catherine C Coombs, et al.
Plos Genetics|April 12, 2008
Genomic islands in the pathogenic filamentous fungus Aspergillus fumigatusNatalie D Fedorova, Nora Khaldi, Vinita S Joardar, et al.
Nature Communications|June 15, 2016
Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamicsEloy F Robles, Maria Mena-Varas, Laura Barrio, et al.
Pageof 61